PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Ignatova, V.V. ; Kaiser, S.* ; Ho, J.S.Y.* ; Bing, X.* ; Stolz, P.* ; Tan, Y.X.* ; Lee, C.L.* ; Gay, F.P.H.* ; Lastres, P.R. ; Gerlini, R. ; Rathkolb, B. ; Aguilar-Pimentel, J.A. ; Sanz-Moreno, A. ; Klein-Rodewald, T. ; Calzada-Wack, J. ; Ibragimov, E. ; Valenta, M. ; Lukauskas, S. ; Pavesi, A.* ; Marschall, S. ; Leuchtenberger, S. ; Fuchs, H. ; Gailus-Durner, V. ; Hrabě de Angelis, M. ; Bultmann, S.* ; Rando, O.J.* ; Guccione, E.* ; Kellner, S.M.* ; Schneider, R.

METTL6 is a tRNA m3C methyltransferase that regulates pluripotency and tumor cell growth.

Sci. Adv. 6:eaaz4551 (2020)
Verlagsversion Forschungsdaten DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Recently, covalent modifications of RNA, such as methylation, have emerged as key regulators of all aspects of RNA biology and have been implicated in numerous diseases, for instance, cancer. Here, we undertook a combination of in vitro and in vivo screens to test 78 potential methyltransferases for their roles in hepatocellular carcinoma (HCC) cell proliferation. We identified methyltransferase-like protein 6 (METTL6) as a crucial regulator of tumor cell growth. We show that METTL6 is a bona fide transfer RNA (tRNA) methyltransferase, catalyzing the formation of 3-methylcytidine at C32 of specific serine tRNA isoacceptors. Deletion of Mettl6 in mouse stem cells results in changes in ribosome occupancy and RNA levels, as well as impaired pluripotency. In mice, Mettl6 knockout results in reduced energy expenditure. We reveal a previously unknown pathway in the maintenance of translation efficiency with a role in maintaining stem cell self-renewal, as well as impacting tumor cell growth profoundly.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
13.116
3.374
31
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Sprache englisch
Veröffentlichungsjahr 2020
HGF-Berichtsjahr 2020
ISSN (print) / ISBN 2375-2548
e-ISSN 2375-2548
Zeitschrift Science Advances
Quellenangaben Band: 6, Heft: 35, Seiten: , Artikelnummer: eaaz4551 Supplement: ,
Verlag American Association for the Advancement of Science (AAAS)
Verlagsort Washington, DC [u.a.]
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Functional Epigenetics (IFE)
Institute of Experimental Genetics (IEG)
POF Topic(s) 30203 - Molecular Targets and Therapies
30201 - Metabolic Health
Forschungsfeld(er) Helmholtz Diabetes Center
Genetics and Epidemiology
PSP-Element(e) G-502800-001
G-500692-001
G-500600-001
DOI 10.1126/sciadv.aaz4551
Scopus ID 85090872221
PubMed ID 32923617
Erfassungsdatum 2020-10-27
[➜Korrektur melden]